MedCity News

AI in Healthcare: Investors’ Green and Red Flags Among Startups

Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition

Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller.

By Frank Vinluan

MedCity Influencers

Business guide to move to the right success direction, leadership to tell solution way, support, help or giving instruction concept, businessman with megaphone tell coworkers to walk the right way.

Why Insurers Need to Lead in the Shift to Healthcare Consumerism

We’re in the middle of a fundamental shift that’s giving consumers more power and choice over their health coverage while creating healthy competition in the marketplace. Consumer expectations are justifiably rising, and people want a much more pleasant, frictionless and digital experience from their health plan – just like they get everyplace else in their lives.

By Alan Stein

MedCity Influencers

Behind “Rise of Malingering” in ER Psychiatry: Why Better Patient Classification Matters

Malingering, deliberately feigning or exaggerating symptoms appears to be rising. This shift brings with it a tangled web of clinical, operational, and ethical challenges that affect not only providers but also the patients most in need of timely, effective care.

By Jim Szyperski

Latest Video

Latest News

Health Tech

Do You Value MedCity News? Take Our Survey!

Take part in our Reader Survey and help us continue to grow!

By Stephanie Baum

Health Tech

Lōvu Health Rakes In $8M for Maternal Health Platform

Lōvu Health's Series A round was led by SJF Ventures and included participation from Rogue Women's Fund, Symphonic Capital, Emmeline Ventures and Majella Ventures.

By Marissa Plescia

Hospitals, Health Tech Artificial Intelligence,

Human bone full body with genomic DNA molecular structure and data on particle background.

Inside Duke’s Approach to Building and Buying AI Tools

Duke University Health System is deploying a mix of homegrown and purchased AI tools to ease clinicians’ administrative burden and improve patient care. Chief Nurse Executive Terry McDonnell highlighted that while AI can’t replace nurses’ judgment, it can help free up their time for what matters most.

By Katie Adams

BioPharma

GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years

President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities.

By Frank Vinluan

MedCity Influencers

Multi Layered Paper Craft Check Mark and Cross Mark in Concentric Circles on Green and Red Background Front View, Right or Wrong Choosing Concept.

The Delegation Dilemma: Why It’s Time for Health Plans to Rethink Vendor-Managed Utilization Management

As an industry, we need to ask hard questions. Are delegated vendors delivering on the promise of better, faster, more transparent decisions? Or are they simply moving the pain to another part of the system?

By Matt Cunningham

MedCity Influencers

Addressing the Primary Care Crisis by Integrating Advanced Practice Providers (APPs)

Since practices tend to build more flexibility into APPs’ schedules, they can efficiently expand patients’ access to care while allowing physicians to focus on more complex patients.

By Joe Nicholson

Payers, Providers

Harbor Health Secures $130M To Grow Insurance Plans and Clinical Footprint

Harbor Health's funding was co-led by General Catalyst, 8VC and Alta Partners. The round also includes participation from Dell Family Office Management, Health 2047 Capital Partners, Lemhi Ventures, Martin Ventures and Breyer Capital.

By Marissa Plescia

BioPharma, Startups

With Drug Picked Up From Sanofi, Startup AllRock Takes Aim at Two Severe Lung Diseases

AllRock Bio’s drug is a small molecule pan-ROCK inhibitor ready for Phase 2 testing in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease. The startup is led by the management team that steered CinCor Pharma to a $1.3 billion acquisition by AstraZeneca.

By Frank Vinluan

MedCity Influencers

Humans Make the Game: What Baseball’s Tech Debate Can Teach Healthcare About the Value of Connection

Healthcare, like baseball, is ultimately a human experience. And no matter how advanced the tools, patients still want to feel something real: that someone sees them, hears them, and cares.

By Michael Oleksiw

MedCity Influencers

Obesity And Cancer as malignant tumor cells in an overweight human body linked to increased risk of certain cancers due to genetics or lifestyle choices oncology

Obesity, Cancer, and the New Frontier of Treatment

Addressing the obesity-cancer connection begins with awareness. The more we understand how excess weight influences cancer risk, the better equipped we are to intervene early, tailor treatment, and support long-term health.

By Robert Den

Health Tech

Berry Street Introduces GLP-1 Nutrition Program

Berry Street's new GLP-1 nutrition program supports patients who are starting GLP-1s, currently taking them or transitioning off of them. Patients receive care from registered dietitians and certified nutrition specialists.

By Marissa Plescia

Hospitals, Health Tech

How HBO’s Emmy-Winning Drama Captures the Chaos Hospitals Workers Face

HBO’s The Pitt won three Emmys for its portrayal of the challenges faced by healthcare workers. Dr. Jason Cohen, a physician and chief medical officer of inpatient at patient flow automation startup Qventus, said the series highlights critical issues like emergency department boarding, staffing shortages and the mental toll on patient care and frontline staff.

By Katie Adams